Es gab 50 kürzliche Insider-Transaktionen für CTI BioPharma Corp. (CTIC), darunter 16 Käufe und 33 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $7.93M und die gesamten Insider-Verkäufe auf $11.78M.
Bedeutende Insider mit kürzlicher Aktivität umfassen Kirske David, Craig Adam R, Fischer Laurent. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — CTIC
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2023-06-26 |
Kirske David |
EVP, Chief Financial Officer |
Aktienrückgabe |
200,000 |
$4.55 |
$910K |
- |
| 2023-06-26 |
Craig Adam R |
President and CEO |
Aktienrückgabe |
900,000 |
$4.55 |
$4.1M |
- |
| 2023-06-26 |
Fischer Laurent |
Director |
Aktienrückgabe |
80,000 |
$4.08 |
$326.4K |
- |
| 2023-06-26 |
Parkinson David Ross |
Director |
Aktienrückgabe |
80,000 |
$4.08 |
$326.4K |
- |
| 2023-06-26 |
Perry Matthew D |
Director |
Aktienrückgabe |
80,000 |
$4.08 |
$326.4K |
- |
| 2023-06-26 |
Metzger Michael A |
Director |
Aktienrückgabe |
80,000 |
$4.08 |
$326.4K |
- |
| 2023-06-26 |
Tuckson Reed Vaughn |
Director |
Aktienrückgabe |
80,000 |
$4.08 |
$326.4K |
- |
| 2023-06-26 |
Parks Diane L. |
Director |
Aktienrückgabe |
80,000 |
$4.08 |
$326.4K |
- |
| 2023-06-26 |
Fong James K |
EVP & Chief Commercial Officer |
Aktienrückgabe |
200,000 |
$4.55 |
$910K |
- |
| 2023-06-26 |
Bvf Partners L P/il |
10 Percent Owner |
Aktienrückgabe |
80,000 |
$4.08 |
$326.4K |
- |
| 2023-04-05 |
Bvf Partners L P/il |
10 Percent Owner |
RSU-Zuteilung |
80,000 |
$4.08 |
$326.4K |
80,000 |
| 2023-04-05 |
Fischer Laurent |
Director |
RSU-Rückgabe |
80,000 |
$4.08 |
$326.4K |
80,000 |
| 2023-04-05 |
Parkinson David Ross |
Director |
RSU-Zuteilung |
80,000 |
$4.08 |
$326.4K |
80,000 |
| 2023-04-05 |
Perry Matthew D |
Director |
RSU-Zuteilung |
80,000 |
$4.08 |
$326.4K |
80,000 |
| 2023-04-05 |
Metzger Michael A |
Director |
RSU-Zuteilung |
80,000 |
$4.08 |
$326.4K |
80,000 |
| 2023-04-05 |
Tuckson Reed Vaughn |
Director |
RSU-Zuteilung |
80,000 |
$4.08 |
$326.4K |
80,000 |
| 2023-04-05 |
Parks Diane L. |
Director |
RSU-Zuteilung |
80,000 |
$4.08 |
$326.4K |
80,000 |
| 2023-03-14 |
Kirske David |
EVP, Chief Financial Officer |
RSU-Zuteilung |
200,000 |
$4.55 |
$910K |
200,000 |
| 2023-03-14 |
Craig Adam R |
President and CEO |
RSU-Zuteilung |
900,000 |
$4.55 |
$4.1M |
900,000 |
| 2023-03-14 |
Fong James K |
EVP & Chief Commercial Officer |
RSU-Zuteilung |
200,000 |
$4.55 |
$910K |
200,000 |
| 2023-01-24 |
Craig Adam R |
President and CEO |
Informierter Verkauf |
2,117 |
$6.01 |
$12.72K |
29,440 |
| 2023-01-24 |
Fong James K |
EVP & Chief Commercial Officer |
Informierter Verkauf |
100,000 |
$6.00 |
$600K |
3,565 |
| 2023-01-03 |
Kirske David |
EVP, Chief Financial Officer |
Informierter Verkauf |
27,021 |
$6.01 |
$162.42K |
17,127 |
| 2023-01-03 |
Craig Adam R |
President and CEO |
Informierter Verkauf |
84,683 |
$6.01 |
$509.22K |
29,440 |
| 2022-12-31 |
Tuckson Reed Vaughn |
Director |
Unbekannt |
- |
- |
- |
- |
| 2022-12-30 |
Kirske David |
EVP, Chief Financial Officer |
RSU-Zuteilung |
214 |
$5.11 |
$1.09K |
17,127 |
| 2022-12-30 |
Craig Adam R |
President and CEO |
RSU-Zuteilung |
1,579 |
$5.11 |
$8.07K |
29,440 |
| 2022-12-29 |
Kirske David |
EVP, Chief Financial Officer |
Informierter Verkauf |
13,174 |
$6.00 |
$79.04K |
16,913 |
| 2022-12-29 |
Craig Adam R |
President and CEO |
Informierter Verkauf |
13,800 |
$6.00 |
$82.8K |
27,861 |
| 2022-11-10 |
Craig Adam R |
President and CEO |
Informierter Verkauf |
2,700 |
$6.04 |
$16.31K |
27,861 |
| 2022-11-09 |
Craig Adam R |
President and CEO |
Informierter Verkauf |
7,596 |
$6.01 |
$45.65K |
28,161 |
| 2022-11-08 |
Metzger Michael A |
Director |
Optionsausübung (Verkauf) |
28,500 |
- |
- |
- |
| 2022-10-04 |
Kirske David |
EVP, Chief Financial Officer |
Informierter Verkauf |
609 |
$6.27 |
$3.82K |
16,913 |
| 2022-10-03 |
Kirske David |
EVP, Chief Financial Officer |
Optionsausübung |
300 |
$0.95 |
$284.67 |
17,213 |
| 2022-09-30 |
Kirske David |
EVP, Chief Financial Officer |
Informierter Verkauf |
139,841 |
$6.05 |
$845.55K |
16,913 |
| 2022-09-29 |
Kirske David |
EVP, Chief Financial Officer |
Optionsausübung |
100 |
$0.95 |
$94.89 |
17,013 |
| 2022-09-16 |
Kirske David |
EVP, Chief Financial Officer |
Informierter Verkauf |
22,592 |
$6.02 |
$136K |
16,913 |
| 2022-08-16 |
Craig Adam R |
President and CEO |
Informierter Kauf |
5,000 |
$5.50 |
$27.5K |
27,861 |
| 2022-08-09 |
Lampert Mark N |
Director |
Umwandlung (Verkauf) |
3,640 |
- |
- |
- |
| 2022-07-07 |
Metzger Michael A |
Director |
Informierter Verkauf |
1,100 |
$6.55 |
$7.21K |
- |
| 2022-07-05 |
Metzger Michael A |
Director |
Optionsausübung (Verkauf) |
91,500 |
- |
- |
28,500 |
| 2022-06-30 |
Kirske David |
EVP, Chief Financial Officer |
RSU-Zuteilung |
9,516 |
$2.12 |
$20.14K |
16,913 |
| 2022-06-30 |
Craig Adam R |
President and CEO |
Informierter Verkauf |
27,000 |
$6.00 |
$162K |
22,861 |
| 2022-06-17 |
Kirske David |
EVP, Chief Financial Officer |
Informierter Verkauf |
50,000 |
$6.25 |
$312.51K |
7,397 |
| 2022-06-14 |
Kirske David |
EVP, Chief Financial Officer |
Informierter Verkauf |
10,000 |
$5.50 |
$55K |
7,397 |
| 2022-06-03 |
Craig Adam R |
President and CEO |
Optionsausübung (Verkauf) |
18,223 |
$0.84 |
$15.33K |
1,227,777 |
| 2022-06-02 |
Craig Adam R |
President and CEO |
Optionsausübung (Verkauf) |
27,000 |
$0.84 |
$22.71K |
1,246,000 |
| 2022-06-01 |
Craig Adam R |
President and CEO |
Informierter Verkauf |
27,000 |
$6.00 |
$162K |
16,678 |
| 2022-06-01 |
Craig Adam R |
President and CEO |
Optionsausübung (Verkauf) |
27,000 |
$0.84 |
$22.71K |
1,273,000 |
| 2022-03-09 |
Lampert Mark N |
Director |
RSU-Zuteilung |
80,000 |
- |
- |
80,000 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
